D-0868-2026 Class II Ongoing

Recalled by Amneal Pharmaceuticals Of New York, LLC — Brookhaven, NY

FDA drug recall D-0868-2026 was initiated by Amneal Pharmaceuticals Of New York, LLC on Aug 28, 2026 and is designated Class II. Reason for recall: Defective Delivery System: Possibility of no medication in the prefilled pen. The recall status is ongoing. Affected quantity: 5,694 pens.

Recall details

Product Type
Drugs
Report Date
Sep 30, 2026
Initiation Date
Aug 28, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,694 pens

Product description

Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1

Reason for recall

Defective Delivery System: Possibility of no medication in the prefilled pen.

Distribution pattern

USA Nationwide

Code information

Lot #: AP250095A, Exp 2/28/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0868-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0868-2026. Report a data issue: hello@regdatalab.com.